methylphenidate

(redirected from Ritalin SR)
Also found in: Dictionary, Thesaurus.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
Hyperlipidemia Sodium and fluid retention increasing risk for hypertension methylphenidate (Ritalin, Treatment of Decreased appetite Ritalin SR, Metadate CD, Attention Deficit leading to weight Metadate ER, Concerta); Hyperactivity loss and poor dextroamphetamine Disorder linear growth.
The ruling will require the following 15 products to be dispensed with new patient medication guides: Adderall tablets, Adderall XR extended-release capsules, Concerta extended-release tablets, Daytrana transdermal system, Desoxyn tablets, Dexedrine Spansule capsules and tablets, Focalin tablets, Fo-calin XR extended-release capsules, Metadate CD extended-release capsules, Methylin oral solution, Methylin chew-able tablets, Ritalin tablets, Ritalin SR sustained-release tablets, Ritalin LA extended-release capsules, and Strattera capsules.
A less-effective, extended-release formulation is marketed as Ritalin SR. SHORT-ACTING FORMULATIONS methylphenidate Available in both generic and trade [Methylin] formulations.